Blog Posts

Novartis Exempts South Dakota, Colorado from 340B Contract Pharmacy Restrictions

Novartis recently exempted North Dakota and Colorado from its 340B contract pharmacy restrictions.
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Analysis: PhRMA Member Restrictions on Health Centers Have More Than Doubled Since NACHC-PhRMA Alliance Formed

A 340B Report analysis finds that a significant number of PhRMA members placed 340B contract pharmacy restrictions on health centers after the NACHC-PhRMA alliance formed in March 2023.
The number of drugmakers that have placed 340B contract pharmacy restrictions on health centers has more than doubled since the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Rhode Island Over 340B Contract Pharmacy Access Law

Drugmakers AbbVie and Novartis recently filed federal lawsuits challenging Rhode Island's new 340B contract pharmacy access law.
Two large pharmaceutical companies this week filed the first federal lawsuits challenging Rhode Island’s recently enacted 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

A Coming Storm—or Opportunity: How the 340B Rebate Pilot and Medicare MFP Could Strain or Strengthen the Drug Supply Chain

SPONSORED CONTENT

The U.S. drug pricing infrastructure is entering a transformative era. On August 1, 2025, the Health Resources and Services Administration (HRSA) announced a voluntary 340B Rebate Model Pilot, aligned with the Inflation Reduction Act’s Maximum Fair Price (MFP) provisions

Read More »

Anti-340B Dark Money Group Promotes GOP-Passed Reconciliation Bill in New Ad

Dark money group Building America’s Future released a 30-second ad touting the new reconciliation budget law, which includes massive Medicaid spending cuts.
The dark money group behind a campaign targeting GOP-led states’ efforts to enact 340B contract pharmacy access laws recently released [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Briefs in Colorado, Tennessee, Utah and Hawaii

Key briefs were filed this week in state 340B contract pharmacy litigation in Colorado, Tennessee, Utah and Hawaii.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital and Pharmacist Groups ask HRSA to Extend 340B Rebate Model Pilot Proposal Timeline

Hospital and pharmacist trade groups asked HRSA Administrator Thomas Engels in an Aug. 8 letter to extend the rebate model pilot proposal's deadlines.
Trade groups representing 340B hospitals and hospital pharmacists recently urged the Health Resources and Services Administration (HRSA) to extend the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Commonwealth Fund Explainer Highlights Key Issues Surrounding 340B Program and Potential Reforms

An Aug. 6 Commonwealth Fund explainer looked at the state of the 340B program and potential reforms.
A prestigious health care think tank recently offered an overview of the 340B program—including criticisms surrounding its growth and drugmakers’ [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

FQHCs Face Unique Challenges—Strong Partnerships Can Make All the Difference

SPONSORED CONTENT

Federally Qualified Health Centers (FQHCs) play a critical role in delivering accessible and affordable healthcare to underserved communities. However, they are facing mounting challenges that threaten their ability to maintain operations and meet growing community needs. With limited infrastructure, evolving regulations, upcoming Medicaid cuts, drops in the insured

Read More »

Sobi, J&J Exempt New States from 340B Contract Pharmacy Restrictions

Drugmakers Sobi and Johnson & Johnson recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access laws.
Two major drugmakers recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live